Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01849627 · ClinicalTrials.gov registry record · NA

Eat Well for Life: A Weight Loss Maintenance Study

A NA study of Obesity, sponsored by The University of Tennessee, Knoxville.

Active
Registry status
NA
Development phase
345
Enrollment target
1
Study location

NCT01849627: Active NA study of Obesity, sponsored by The University of Tennessee, Knoxville.

NCT01849627 is a NA study of Obesity that is active but no longer recruiting, run by The University of Tennessee, Knoxville. The registered enrollment target is 345 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01849627, a NA study of Obesity, is active but no longer recruiting, sponsored by The University of Tennessee, Knoxville.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
345 participants
Enrollment target
1
Study location

Study Summary

A study to investigate the effect of a low-ED prescription (consume ≥10 foods ≤ 1.0 kcal/g and ≤ 2 foods ≥ 3.0 kcal/g per day) versus an energy balance prescription (consume a daily energy intake at estimated energy needs for maintenance) on weight loss maintenance.

Primary Outcome

Height, weight, and BMI will be assessed.

Conditions Studied

Interventions

  • BEHAVIORAL Low-ED
  • BEHAVIORAL Energy Balance

Study Locations (1)

Tennessee

  • University of Tennessee - Knoxville

Trial Details

FieldValue
Enrollment Target 345 participants
Start Date 2014-08
Est. Completion 2025-12-31
Phase NA

What the registry record for NCT01849627 still lists

NCT01849627 is an interventional study that assigns participants to a tested intervention. The registered 345 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (58% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Low-ED is the first listed.

NCT01849627 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT01849627 about?

NCT01849627 is a clinical study titled "Eat Well for Life: A Weight Loss Maintenance Study". A study to investigate the effect of a low-ED prescription (consume ≥10 foods ≤ 1.0 kcal/g and ≤ 2 foods ≥ 3.0 kcal/g per day) versus an energy balance prescription (consume a daily energy intake at estimated energy needs for maintenance) on weight loss maintenance.

What is the current status of trial NCT01849627?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 345 participants. The study started on 2014-08. Estimated completion is 2025-12-31.

What conditions does trial NCT01849627 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT01849627?

The interventions under investigation include: Low-ED (BEHAVIORAL), Energy Balance (BEHAVIORAL).

Who is sponsoring clinical trial NCT01849627?

This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01849627 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01849627's enrollment target sits among peer trials

345 191st of 1053 higher than 863 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03972657 · 345 participants · Phase 1

    A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

  • NCT05107674 · 345 participants · Phase 1

    A Study of NX-1607 in Adults With Advanced Malignancies

  • NCT05700279 · 345 participants · NA

    Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset

  • NCT05781100 · 345 participants · NA

    Investigating Baby Behavior and Family Technology Use Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01849627, the US trial registry maintained by the National Library of Medicine. NCT01849627 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.